This study aims to create the evidence for optimizing the management of hypertension in the elderly. The main findings are as follows. 1. Korean National Health and Nutrition Survey data and the Health Insurance Corporation big data analysis - The pre...
This study aims to create the evidence for optimizing the management of hypertension in the elderly. The main findings are as follows. 1. Korean National Health and Nutrition Survey data and the Health Insurance Corporation big data analysis - The prevalence of hypertension in the elderly population continues to increase, and the recognition rate and treatment rate are high at 80% or higher, while the control rate is low at 60%. Older people tend to have multiple comorbidities, and medical expenses are higher. The older people are, the higher the compliance with medication. Compared to hypertensive patients under 65 years of age, patients with hypertension over 65 years of age had a higher rate of taking antihypertensive drugs with three or more components, and the rate of taking calcium channel blockers was higher than those under 65 years of age. The mortality rate was lower when the average systolic blood pressure was 130-140 mmHg compared to the case where the average systolic blood pressure was more than 140 mmHg, and the mortality rate was lower when the average diastolic blood pressure was 80-90 mmHg compared to the case of 90 mmHg or more. 2. Systematic review and meta-analysis - In hypertensive patients 65 years of age or older, the intensive treatment group aimed at lower blood pressure showed an improvement in cardio-cerebrovascular disease risk by about 20%. However, only five clinical studies have been well-planned and conducted according to target blood pressure in hypertensive patients over 65 years of age, and the heterogeneity between each studies is high, so additional verification is needed for the effect of intensive hypertension treatment in the elderly.